Publications by authors named "Shinobu Ashida"

Claim this Profile
C
Comparison of the effects of cefmetazole and meropenem on microbiome: A pilot study.
Kayoko Hayakawa, Sho Saito, Tohru Miyoshi-Akiyama, Yuto Fukui, Norihiko Takemoto, Shinobu Ashida

J Infect Chemother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unit costs of health services provided at hospitals and health centres in two provinces of Zambia.
Patrick Banda, Yuta Yokobori, Shinobu Ashida, Felix Masiye, Oliver Kaonga

GHM Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial.
Sho Saito, Satoshi Kutsuna, Imamura Akifumi, Ryota Hase, Rentaro Oda, Shinobu Ashida

J Infect Chemother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox.
Tetsuya Suzuki, Sho Saito, Shinya Tsuzuki, Shinobu Ashida, Mizue Takakusaki

BMJ Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement.
Tetsuya Suzuki, Noriko Iwamoto, Shinya Tsuzuki, Yuko Kakumoto, Michiyo Suzuki, Shinobu Ashida

Eur J Clin Invest· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).
Noriko Tomita, Sho Saito, Junko Terada-Hirashima, Ayako Mikami, Yukari Uemura, Shinobu Ashida

Life (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants.
Mikako Ueno, Naoko Iwata-Yoshikawa, Akihiro Matsunaga, Tadashi Okamura, Sho Saito, Shinobu Ashida

Antiviral Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Prolonged Psychological Distress Among Nurses and Physicians Engaged in COVID-19 Patient Care in Singapore and Japan.
Shinichiro Morioka, Ban Hock Tan, Hiroe Kikuchi, Yusuke Asai, Tetsuya Suzuki, Shinobu Ashida

Front Psychiatry· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan.
Sho Saito, Kayoko Hayakawa, Ayako Mikami, Shinyu Izumi, Hideki Funazaki, Shinobu Ashida

Glob Health Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis